Dr. Shaoying Li, MD

Dr. Li practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Li's NPI, 1942410287, was assigned on May 23, 2007. Dr. Li graduated from Beijing Medical University in 1990. Dr. Li holds Texas license N9590.

Dr. Li's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Li's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Li is board certified in hematopathology by the American Board of Pathology. Dmand AI has Dr. Li's licenses on file in 3 states: Texas, Alabama and Tennessee.

CMS data shows 1,923 Medicare services from Dr. Li across 13 procedure codes in 2024, for 494 Medicare patients. Medicare paid $56,161 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 494 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 64, with 51% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Li for performance year 2024, reported as part of a group. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 130 papers to Dr. Li, published from 2005 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Biomarkers, Tumor, Lymphoma, Large B-Cell, Diffuse and Proto-Oncogene Proteins c-myc. Dr. Li has published most often in Mod Pathol. Dr. Li's most frequent co-authors are Leonard Jeffrey Medeiros, MD, Guilin Tang, MD and Sa A. Wang, MD.

CMS Open Payments shows 1 general payment to Dr. Li from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $123.

Dr. Li graduated from Beijing Medical University in 1990. Dr. Li is a member of ASH.

Dr. Li is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.